Mechanism of IL-lβ-induced increase in intestinal epithelial tight junction permeability

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5653-5661

  Al Sadi, Rana ^a   Ye, Dongmei ^a   Dokladny, Karol ^a   Ma, Thomas Y ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; MYOSIN L CHAIN KINASE; PHOSPHOTRANSFERASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MYOSIN LIGHT CHAIN KINASE;

ARTICLE; CELL MEMBRANE PERMEABILITY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION; CELL STRAIN CACO 2; GENETICS; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY;

CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; HUMANS; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MYOSIN-LIGHT-CHAIN KINASE; NF-KAPPA B; RNA, SMALL INTERFERING; TIGHT JUNCTIONS; TRANSCRIPTION, GENETIC;

EID: 45949086355     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5653     Document Type: Article

References (70)

1. Hollander, D. 1988. Crohn's disease: a permeability disorder of the tight junction? Gut 29: 1621-1624.
2. Ma, T. Y. 1997. Intestinal epithelial barrier dysfunction in Crohn's disease. Proc. Soc. Exp. Biol. Med. 214: 318-327.
3. Berkes, 1, V. K. Viswanathan, S. D. Savkovic, and G. Hecht. 2003. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439-451.
4. Hollander, D. 1999. Intestinal permeability, leaky gut, and intestinal disorders. Curr. Gastroenterol. Rep. 1: 410-416.
5. Anderson, J. M., and C. M. Van Itallie. 1995. Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol. 269: G467-G475.
6. Dimitrijevic, O. B., S. M. Stamatovic, R. F. Keep, and A. V. Andjelkovic. 2006. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-rep erfusion injury. J. Cereb. Blood Flow Metab. 26: 797-810.
7. Martin-Padura, I., S. Lostaglio, M. Schneemann, L. Williams, M. Romano, P. Fruscella, C. Panzeri, A. Stoppacciaro, L. Ruco, A. Villa, et al. 1998. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142: 117-127.
8. Al-Sadi, R. M., and T. Y. Ma. 2007. IL-1β causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178: 4641-4649.
9. Chiba, H., T. Kojima, M. Osanai, and N. Sawada. 2006. The significance of interferon-γ-triggered internalization of tight-junction proteins in inflammatory bowel disease. Sci. STKE 2006: pel.
10. Wang, F., W. V. Graham, Y. Wang, E. D. Witkowski, B. T. Schwarz, and J. R. Turner. 2005. Interferon-γ and tumor necrosis factor-α synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am. J. Pathol. 166: 409-419.
11. Wang, F., B. T. Schwarz, W. V. Graham, Y. Wang, L. Su, D. R. Clayburgh, C. Abraham, and J. R. Turner. 2006. IFN-γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131: 1153-1163.
12. Weber, C. R., and J. R. Turner. 2007. Inflammatory bowel disease: is it really just another break in the wall? Gut 56: 6-8.
13. Clayburgh, D. R., L. Shen, and J. R. Turner. 2004. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84: 282-291.
14. Chen, M. L., Z. Ge, J. G. Fox, and D. B. Schauer. 2006. Disruption of tight junctions and induction of pro inflammatory cytokine responses in colonic epithelial cells by Campylobacter jejuni. Infect. Immun. 74: 6581-6589.
15. Savkovic, S. D., A. Ramaswamy, A. Koutsouris, and G. Hecht. 2001. EPEC- activated ERK1/2 participate in inflammatory response but not tight junction barrier disruption. Am. J. Physiol. 281: G890-G898.
16. Watson, C. J., C. J. Hoare, D. R. Garrod, G. L. Carlson, and G. Warhurst. 2005. Interferon-γ selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores. J. Cell Sci. 118: 5221-5230.
17. Boivin, M. A., D. Ye, J. C. Kennedy, R. Al-Sadi, C. Shepela, and T. Y. Ma. 2007. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am. J. Physiol. 292: G590-G598.
18. Utech, M., A. I. Ivanov, S. N. Samarin, M. Bruewer, J. R. Turner, R. J. Mrsny, C. A. Parkos, and A. Nusrat. 2005. Mechanism of IFN-y-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol. Biol. Cell 16: 5040-5052.
19. Monteleone, G., D. Fina, R. Caruso, and F. Pallone. 2006. New mediators of immunity and inflammation in inflammatory bowel disease. Curr. Opin. Gastroenterol. 22: 361-364.
20. +-ATPase in the rat jejunum and kidney. J. Interferon Cytokine Res. 22: 1041-1048.
21. O'Neill, L. A. 2000. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2000: rel.
22. Dunne, A., and L. A. O'Neill. 2003. The interleukin-1 receptorAToll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2003: re3.
23. Dinarello, C. A. 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8: 1314-1325.
24. Stylianou, E., and J. Saklatvala. 1998. Interleukin-1. Int. J. Biochem. Cell. Biol. 30: 1075-1079.
25. Carty, E., M. De Brabander, R. M. Feakins, and D. S. Rampton. 2000. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper. Gut 46: 487-492.
26. Reinecker, H. C., M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R. P. MacDermott, and A. Raedler. 1993. Enhanced secretion of tumour necrosis factor-a, IL-6, and IL-1 β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94: 174-181.
27. Cominelli, F., and T. T. Pizarro. 1996. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment. Pharmacol. Ther. 10 (Suppl. 2) : 49-54.
28. Mittal, R. D., H. K. Bid, and U. C. Ghoshal. 2005. IL-1 receptor antagonist (IL-IRa) gene polymorphism in patients with inflammatory bowel disease in India. Scand. J. Gastroenterol. 40: 827-831.
29. Heresbach, D., M. Alizadeh, A. Dabadie, N. Le Berre, J. F. Colombel, J. Yaouanq, J. F. Bretagne, and G. Semana. 1997. Significance of interleukin-1β and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am. J. Gastroenterol. 92: 1164-1169.
30. Nemetz, A., M. P. Nosti-Escanilla, T. Molnar, A. Kope, A. Kovacs, J. Feher, Z. Tulassay, F. Nagy, M. A. Garcia-Gonzalez, and A. S. Pena. 1999. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immuno genetics 49: 527-531.
31. Barksby, H. E., S. R. Lea, P. M. Preshaw, and J. J. Taylor. 2007. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol. 149: 217-225.
32. Dinarello, C. A. 2003. Anti-cytokine therapeutics and infections. Vaccine 21 (Suppl. 2) : S24-S34.
33. Brun, P., I. Castagliuolo, V. D. Leo, A. Buda, M. Pinzani, G. Palu, and D. Martines. 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. 292: G518-G525.
34. Sun, Z., K. Olanders, A. Lasson, M. Dib, M. Annborn, K. Andersson, X. Wang, and R. Andersson. 2002. Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1. J. Surg. Res. 105: 220-233.
35. Shen, L., E. D. Black, E. D. Witkowski, W. I. Lencer, V. Guerriero, E. E. Schneeberger, and J. R. Turner. 2006. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J. Cell Sci. 119: 2095-2106.
36. Ye, D., I. Ma, and T. Y. Ma. 2006. Molecular mechanism of tumor necrosis factor-α modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. 290: G496-G504.
37. Ma, T. Y., D. Tran, N. Hoa, D. Nguyen, M. Merryfield, and A. Tarnawski. 2000. Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskelet al. involvement. Microsc. Res. Tech. 51: 156-168.
38. Clayburgh, D. R., S. Rosen, E. D. Witkowski, F. Wang, S. Blair, S. Dudek, J. G. Garcia, J. C. Alverdy, and J. R. Turner. 2004. A differentiation- dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability. J. Biol. Chem. 279: 55506-55513.
39. Ma, T. Y., D. Hollander, L. T. Tran, D. Nguyen, N. Hoa, and D. Bhalla. 1995. Cytoskelet al. regulation of Caco-2 intestinal monolayer paracellular permeability. J. Cell Physiol. 164: 533-545.
40. Ma, T. Y., N. T. Hoa, D. D. Tran, V. Bui, A. Pedram, S. Mills, and M. Merryfield. 2000. Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase. Am. J. Physiol. 279: G875-G885.
41. Ma, T. Y., D. Nguyen, V. Bui, H. Nguyen, and N. Hoa. 1999. Ethanol modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. 276: G965-G974.
42. + exchanger NHE3. Am. J. Physiol. 279: C1918-C1924.
43. Hecht, G., C. Pothoulakis, J. T. LaMont, and J. L. Madara. 1988. Clostridium difficile toxin A perturbs cytoskelet al. structure and tight junction permeability of cultured human intestinal epithelial monolayers. J. Clin. Invest. 82: 1516-1524.
44. Spitz, J., R. Yuhan, A. Koutsouris, C. Blatt, J. Alverdy, and G. Hecht. 1995. Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers diminishes barrier function. Am. J. Physiol. 268: G374-G379.
45. Hecht, G., L. Pestic, G. Nikcevic, A. Koutsouris, J. Tripuraneni, D. D. Lorimer, G. Nowak, V. Guerriero, Jr., E. L. Elson, and P. D. Lanerolle. 1996. Expression of the catalytic domain of myosin light chain kinase increases paracellular permeability. Am. J. Physiol. Til: C1678-C1684.
46. Ma, T. Y., M. A. Boivin, D. Ye, A. Pedram, and H. M. Said. 2005. Mechanism of TNF-α modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am. J. Physiol. 288: G422-G430.
47. Blair, S. A., S. V. Kane, D. R. Clayburgh, and J. R. Turner. 2006. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab. Invest. 86: 191-201.
48. Dokladny, K., P. L. Moseley, and T. Y. Ma. 2006. Physiologically relevant increase in temperature causes an increase in intestinal epithelial tight junction permeability. Am. J. Physiol. 290: G204-G212.
49. Ma, T. Y., G. K. Iwamoto, N. T. Hoa, V. Akotia, A. Pedram, M. A. Boivin, and H. M. Said. TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am. J. Physiol. 286: G367-G376.
50. O'Neill, L. A., and C. A. Dinarello. 2000. The IL-1 receptor/to 11-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 21: 206-209.
51. Nakamura, M., H. Saito, J. Kasanuki, Y. Tamura, and S. Yoshida. 1992. Cytokine production in patients with inflammatory bowel disease. Gut 33: 933-937.
52. Ligumsky, M., P. L. Simon, F. Karmeli, and D. Rachmilewitz. 1990. Role of interleukin 1 in inflammatory bowel disease: enhanced production during active disease. Gut 31: 686-689.
53. Hardin, J., K. Kroeker, B. Chung, and D. G. Gall. 2000. Effect of proinflammatory interleukins onjejunal nutrient transport. Gut 47: 184-191.
54. Matysiak-Budnik, T., A. Thomas-Collignon, F. Megraud, and M. Heyman. 2001. Alterations of epithelial permeability by Helicobacter and IL-1β in vitro: protective effect of rebamipide. Dig. Dis. Sci. 46: 1558-1566.
55. p/ROCK and MLCK in TNF- α-induced changes in endothelial morphology and permeability. J. Cell. Physiol. 213: 221-228.
56. Turner, J. R. 2000. "Putting the squeeze" on the tight junction: understanding cytoskelet al. regulation. Semin. Cell. Dev. Biol. 11: 301-308.
57. Madara, J. L., D. Barenberg, and S. Carlson. 1986. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J. Cell Biol. 102: 2125-2136.
58. Ferrier, L., L. Mazelin, N. Cenac, P. Desreumaux, A. Janin, D. Emilie, J. F. Colombel, R. Garcia-Villar, J. Fioramonti, and L. Bueno. 2003. Stressinduced disruption of colonic epithelial barrier: role of interferon-y and myosin light chain kinase in mice. Gastroenterology 125: 795-804.
59. Cenac, N., A. C. Chin, R. Garcia-Villar, C. Salvador-Cartier, L. Ferrier, N. Vergnolle, A. G. Buret, J. Fioramonti, and L. Bueno. 2004. PAR2 activation alters colonic paracellular permeability in mice via IFN-γ-dependent and -independent pathways. J. Physiol. 558: 913-925.
60. Madara, J. L., J. Stafford, D. Barenberg, and S. Carlson. 1988. Functional coupling of tight junctions and microfilaments in T84 monolayers. Am. J. Physiol. 254: G416-G423.
61. Prahalad, P., I. Calvo, H. Waechter, J. B. Matthews, A. Zuk, and K. S. Matlin. 2004. Regulation of MDCK cell-sub stratum adhesion by RhoA and myosin light chain kinase after ATP depletion. Am. J. Physiol. 286: C693-C707.
62. Murthy, K. S. 2006. Signaling for contraction and relaxation in smooth muscle of the gut. Annu. Rev. Physiol. 68: 345-374.
63. p-associated kinase in vascular smooth muscle contraction. Curr. Hypertens. Rep. 5: 66-72.
64. Walsh, M. P., M. Susnjar, J. Deng, C. Sutherland, E. Kiss, and D. P. Wilson. 2007. Phosphorylation of the protein phosphatase type 1 inhibitor protein CPI-17 by protein kinase C. Methods Mol. Biol. 365: 209-223.
65. Wu, X., A. V. Somlyo, and A. P. Somlyo. 1996. Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate. Biochem. Biophys. Res. Commun. 220: 658-663.
66. + and decreased cGMP-induced relaxation. Proc. Natl. Acad. Sci. USA 103: 2440-2445.
67. Sobieszek, A., O. Y. Andruchov, Z. Grabarek, N. Kulikova, C. Liebetrau, and O. S. Matusovsky. 2005. Modulation of myosin filament activation by telokin in smooth muscle liberation of myosin kinase and phosphatase from supramolecular complexes. Biophys. Chem. 113: 25-40.
68. Norwood, N., T. M. Moore, D. A. Dean, R. Bhattacharjee, M. Li, and T. Stevens. 2000. Store-operated calcium entry and increased endothelial cell permeability. Am. J. Physiol. 279: L815-L824.
69. Yuan, S. Y., M. H. Wu, E. E. Ustinova, M. Guo, J. H. Tinsley, P. De Lanerolle, and W. Xu. 2002. Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circ. Res. 90: 1214-1221.
70. Graham, W. V., F. Wang, D. R. Clayburgh, J. X. Cheng, B. Yoon, Y. Wang, A. Lin, and J. R. Turner. 2006. Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events: characterization of the human long myosin light chain kinase promoter. J. Biol. Chem. 281: 26205-26215.